3.5. Defining CTLA4+, IFN-γ+, and CTLA4+IFN-γ+ Cells Using the CD3 Marker for T Lymphocytes in KA, SCC, and, VV Tumor Microenvironments. The gene discussed is IFNG; the disease is neoplasm.